A 62-year-old man had an acute episode of hypertension 72 h after fine needle aspiration biopsy of an intrahepatic nodule. The patient had been operated 3 years previously for a right adrenal phaeochromocytoma with no evidence of metastases at that time. Thus, a relapse of the tumour was postulated and confirmed by raised levels of urinary metanephrines. The extent of the metastases precluded surgical intervention and thus localised embolisation was proposed and permitted a clinical Keywords: phaeochromocytoma; metastases; fine needle aspiration biopsy; embolisation A 62-year-old man was hospitalised 72 h after a fine needle aspiration biopsy of a hepatic nodule with headache, sweats, palpitations and vertigo. He was found to have a very high blood pressure (200/100 mm Hg). Three years previously, he had had several hypertensive crises with blood pressure rising to 240/140 mm Hg, with similar symptoms. The diagnosis of a right sided adrenal phaeochromocytoma was established by urinary metanephrine levels (87 mol/24 h, normal Ͻ4.2) and by abdominal CT scan which showed a heterogeneous right adrenal mass (80 × 70 mm) (Figure 1 ). There was no evidence of spread of the tumour to other sites. After the introduction of treatment with labetolol at 200 mg/day the patient underwent total resection of the right adrenal tumour. Histological examination confirmed an adrenal phaeochromocytoma of 181 grams with areas of haemorrhagic necrosis and no evidence of extension beyond the capsule. The post-operative period was uneventful and the patient was asymptomatic without any treatment. Follow-up was limited to an annual abdominal ultrasound examination and nothing abnormal was found until the discovery 3 years after the original intervention of two nodules in the segment VI of the liver. It was following a fine needle aspiration biopsy of one of these nodules that the patient was hospitalised in our unit for a hypertensive crisis. The histological and cytological examination of the samples showed only normal liver tissue. The diagnosis of metastasis from a phaeochromocytoma was postulated and confirmed by the levels of urinary metanephrines (23 mol/24 h). A CT scan of the abdomen (Figure 2 ) demonstrated three hepatic lesions in segments VI and VII, the largest being 50 × 40 mm. Thoracic CT scan was normal and total body scan by metaiodobenzylguanidine (MIBG) showed uptake not only in the liver but also in the
A 62-year-old man was hospitalised 72 h after a fine needle aspiration biopsy of a hepatic nodule with headache, sweats, palpitations and vertigo. He was found to have a very high blood pressure (200/100 mm Hg). Three years previously, he had had several hypertensive crises with blood pressure rising to 240/140 mm Hg, with similar symptoms. The diagnosis of a right sided adrenal phaeochromocytoma was established by urinary metanephrine levels (87 mol/24 h, normal Ͻ4.2) and by abdominal CT scan which showed a heterogeneous right adrenal mass (80 × 70 mm) ( Figure 1 ). There was no evidence of spread of the tumour to other sites. After the introduction of treatment with labetolol at 200 mg/day the patient underwent total resection of the right adrenal tumour. Histological examination confirmed an adrenal phaeochromocytoma of 181 grams with areas of haemorrhagic necrosis and no evidence of extension beyond the capsule. The post-operative period was uneventful and the patient was asymptomatic without any treatment. Follow-up was limited to an annual abdominal ultrasound examination and nothing abnormal was found until the discovery 3 years after the original intervention of two nodules in the segment VI of the liver. It was following a fine needle aspiration biopsy of one of these nodules that the patient was hospitalised in our unit for a hypertensive crisis. The histological and cytological examination of the samples showed only normal liver tissue. The diagnosis of metastasis from a phaeochromocytoma was postulated and confirmed by the levels of urinary metanephrines (23 mol/24 h). A CT scan of the abdomen ( Figure 2 ) demonstrated three hepatic lesions in segments VI and VII, the largest being 50 × 40 mm. Thoracic CT scan was normal and total body scan by metaiodobenzylguanidine (MIBG) showed uptake not only in the liver but also in the left sacro-iliac joint and the left iliac wing ( Figure  3 ). The diagnosis of multiple metastases from a phaeochromocytoma was reached and a laparotomy was proposed to reduce the mass of tumour. Unfortunately the surgeon found multiple hepatic metastases and invasion of the diaphragm, colon and peritoneum which precluded excision of the tumour. Histological examination confirmed the diagnosis of metastases from a phaeochromocytoma. In view of the volume of tumour found in comparison to the uptake of radio-isotope on the scan, the possibility of MIBG radiotherapy was not considered feasible. The patient remained stable for 12 months with labetolol 200 mg per day. Then, he had repeated hypertensive crises with blood pressure levels rising to 270/120 mm Hg and marked elevation of urinary metanephrine (70 mol/24 h). Arteriography demonstrated the sites of the lytic bone metastases (sacral, lumbar and iliac). Thus, selective embolisation of the two largest hepatic metastases and the lumbo-sacral lesions was performed. The immediate follow-up was marked by a severe but transitory high blood pressure (240/120 mm Hg). The subsequent evolution was positive with treatment by atenolol 100 mg and prazosin 2 mg per day. Clinical signs of tumour extension abated together with a fall in urinary metanephrine levels (11 mol/24 h). A CT scan after the embolisation showed partial necrosis of the tumour masses. Eight months later, there was a clinical relapse with hypertensive episodes of 230/120 mm Hg and an increase in the urinary metanephrine levels to 229 mol/24 h. The patient died 1 month later from a sudden cerebrovascular accident.
Fifteen percent of phaeochromocytomas are sited outside the adrenals, 85% are unilateral and 10% are malignant. Malignancy should be suspected in the case of voluminous tumours but there are no specific histological criteria other than the presence of metastases. The volume of the tumour is also a good predictor of a malignant evolution. Metastases occur in about 10% of cases and are usually in the liver, bone or lymph nodes. 1 These can appear up to 20 years after the initial resection. 2 In our case, the discovery of hepatic and bone metastases occurred 3 years after the adrenal resection. Since the initial tumour was large (Ͼ50 mm), relapse was more likely in our case as also occurs when the tumour is bilateral or from outside the adrenal. 1 The frequency of malignant evolution and its subsequent poor prognosis justify an annual review after the operation with surveillance of blood pressure, urinary metanephrines and abdominal ultrasound. Fine needle aspiration biopsy is a specific and sensitive technique in the diagnosis of primary or secondary adrenal tumours. However, puncture of a tumour mass likely to secrete catecholamines is contraindicated because of the risk of massive increase in blood pressure and associated haemorrhage. 3 Most reports of the diagnosis of phaeochromocytoma by fine needle aspiration biopsy of an adrenal mass were in situations where the diagnosis was unlikely on the basis of clinical history or hormonal levels. In our case, fine needle aspiration biopsy was performed in spite of the possibility of a phaeochromocytoma. An explanation of the 72-h delay in symptoms after the needle aspiration may be that the metastasis was pierced by the needle with necrosis in situ since the sample did not reveal tumour cells.
Treatment of malignant phaeochromocytoma is disappointing. Intravenous chemotherapy and external beam radiotherapy are not very effective. The use of MIBG labelled with Iodine 131 has only shown an effect in less than 50% of cases, usually when the tumour shows significant uptake of MIBG. 4 As in the present case, selective arterial embolisation of accessible tumour masses may be carried out in order to reduce tumour volume by necrosis and also to reduce the level of secretion of catecholamines. 5 This procedure may be followed by a transitory increase in blood pressure by spillover of catecholamines into the circulation and thus requires close supervision of the blood pressure for 48 h. Embolisation is only a palliative treatment with the objective of reducing symptoms of catJournal of Human Hypertension echolamine excess as was the case for 8 months in our patient. More diffuse lesions are not accessible to this technique which may explain the reappearance of hypertensive crises in our patient who had peritoneal lesions. All these may explain why the survival of patients with malignant phaeochromocytoma is less then 50% at 5 years. 6 In conclusion, post-operative follow-up with blood pressure surveillance, measurement of metanephrine levels and abdominal ultrasound should be carried out annually in patients operated for a phaeochromocytoma even if considered as likely to be benign. If an abnormal mass is found, especially in the liver, needle biopsy is contraindicated because of increased risk of severe rises in blood pressure or haemorrhage. Arterial embolisation is one method of some efficacy in the case of well circumscribed metastases.
